Technology

Kamada

$6.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-3.73%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Kamada and other stocks, options, and ETFs commission-free!

About KMDA

Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel. The listed name for KMDA is Kamada Ltd. Ordinary Shares.

CEO
Amir London
Employees
429
Headquarters
Rehovot, HaMerkaz
Founded
1990
Market Cap
305.55M
Price-Earnings Ratio
14.38
Dividend Yield
—
Average Volume
165.71K
High Today
$7.15
Low Today
$6.85
Open Price
$7.11
Volume
159.31K
52 Week High
$13.33
52 Week Low
$4.40

Collections

KMDA Earnings

$0.00
$0.05
$0.10
$0.15
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 11, Pre-Market

You May Also Like

AAIC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure